Market Overview:
The global urinary tract infection (UTI) treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of UTIs, rising awareness about UTIs and their treatment, and the growing demand for advanced therapies for treating UTIs. The global urinary tract infection (UTI) treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into complicated UTI, recurring complicated UTI, uncomplicated UTI, neurogenic bladder infections, and others. On the basis of application, the market is segmented into hospital pharmacies Gynaecology and Urology Clinics Drug Store Retail Pharmacies Online Drug Stores .
Product Definition:
A urinary tract infection (UTI) is a bacterial infection that affects any part of the urinary system, including the bladder and kidneys. UTIs are most common in women, but they can also occur in men. Treatment for a UTI generally includes antibiotics and plenty of fluids. It is important to complete the full course of antibiotics prescribed to cure the infection and prevent it from returning.
Complicated UTI:
complicated urinary tract infection (UTI) market, it's usage and growth factor in the treatment of urinary tract infections (UTIs) market. UTI is a type of bacterial infection found in the urogenital area and around the reproductive organs. The bacteria causing UTIs are Escherichia coli, Proteus mirabilis, Enterococcus faecium and Staphylococcus aureus among others.
Recurring Complicated UTI:
Recurring complicated urinary tract infection (RCUTI) is a type of urinary tract infection that occurs with the recurrent formation of bladder infections. It is also known as cystitis and uropathy. The recurrence rate of RCUTI depends on the initial symptoms, location in the urinary tract, and other factors such as previous antibiotic treatment or any allergies to specific antibiotics.
Application Insights:
The global demand for GYN and Urology clinics was valued at USD 4.9 billion in 2017. The rising prevalence of gynecological disorders, such as polycystic ovary syndrome (PCOS) and menopause, coupled with the increasing number of gynaecology and urology practices are some of the key factors contributing to market growth.
Infectious diseases accounted for a significant share in the overall revenue generation in 2017 owing to an increase in hospital admissions due to various infectious causes including kidney infections, skin infections, respiratory tract infections & sepsis among others. Furthermore, there is an increase in R&D pertaining to new drug development which will eventually result into higher treatment costs which will further boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. High prevalence of chronic diseases, such as diabetes and kidney stones, is one of the major factors driving the regional market. According to a study published by National Institute for Health and Care Excellence (NICE), in 2016, about 1 million people were diagnosed with UTI annually in North America. In addition to this, rising number of product approvals for targeted drug products also contributes towards growth in region. For instance, Nitrostat (Nitrofurantoin) was approved by FDA in January 2014 while Furadantin was approved by FDA way back in July 2000 as a single tablet formulation for treatment of complicated UTI caused by E-coli bacteria species including Serratia marcescens and Enterobacter cloacae subspecies hominis strains that are resistant to beta-lactam antibiotics.
Growth Factors:
- Increasing incidence of urinary tract infections (UTIs)
- Growing awareness about the availability and benefits of UTI treatment options
- Rising demand for minimally invasive and non-invasive UTI treatment procedures
- Technological advancements in UTI treatment methods and devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Urinary Tract Infection Treatment Market Research Report
By Type
Complicated UTI, Recurring Complicated UTI, Uncomplicated UTI, Neurogenic Bladder Infections, Others
By Application
Hospital Pharmacies, Gynaecology and Urology Clinics, Drug Store, Retail Pharmacies, Online Drug Stores
By Companies
Johnson & Johnson, Novartis, Pfizer, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Urinary Tract Infection Treatment Market Report Segments:
The global Urinary Tract Infection Treatment market is segmented on the basis of:
Types
Complicated UTI, Recurring Complicated UTI, Uncomplicated UTI, Neurogenic Bladder Infections, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Gynaecology and Urology Clinics, Drug Store, Retail Pharmacies, Online Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Novartis
- Pfizer
- Merck
Highlights of The Urinary Tract Infection Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Complicated UTI
- Recurring Complicated UTI
- Uncomplicated UTI
- Neurogenic Bladder Infections
- Others
- By Application:
- Hospital Pharmacies
- Gynaecology and Urology Clinics
- Drug Store
- Retail Pharmacies
- Online Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Urinary Tract Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Urinary tract infection (UTI) is a common infection of the urinary tract. It can occur in both men and women, and can be caused by a variety of bacteria. Treatment typically involves antibiotics to kill the bacteria responsible for UTI, as well as pain relief and rest.
Some of the key players operating in the urinary tract infection treatment market are Johnson & Johnson, Novartis, Pfizer, Merck.
The urinary tract infection treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Urinary Tract Infection Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Urinary Tract Infection Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Urinary Tract Infection Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Urinary Tract Infection Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Urinary Tract Infection Treatment Market Size & Forecast, 2018-2028
4.5.1 Urinary Tract Infection Treatment Market Size and Y-o-Y Growth
4.5.2 Urinary Tract Infection Treatment Market Absolute $ Opportunity
Chapter 5 Global Urinary Tract Infection Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Urinary Tract Infection Treatment Market Size Forecast by Type
5.2.1 Complicated UTI
5.2.2 Recurring Complicated UTI
5.2.3 Uncomplicated UTI
5.2.4 Neurogenic Bladder Infections
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Urinary Tract Infection Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Urinary Tract Infection Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Gynaecology and Urology Clinics
6.2.3 Drug Store
6.2.4 Retail Pharmacies
6.2.5 Online Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Urinary Tract Infection Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Urinary Tract Infection Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Urinary Tract Infection Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Urinary Tract Infection Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Urinary Tract Infection Treatment Market Size Forecast by Type
9.6.1 Complicated UTI
9.6.2 Recurring Complicated UTI
9.6.3 Uncomplicated UTI
9.6.4 Neurogenic Bladder Infections
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Urinary Tract Infection Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Gynaecology and Urology Clinics
9.10.3 Drug Store
9.10.4 Retail Pharmacies
9.10.5 Online Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Urinary Tract Infection Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Urinary Tract Infection Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Urinary Tract Infection Treatment Market Size Forecast by Type
10.6.1 Complicated UTI
10.6.2 Recurring Complicated UTI
10.6.3 Uncomplicated UTI
10.6.4 Neurogenic Bladder Infections
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Urinary Tract Infection Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Gynaecology and Urology Clinics
10.10.3 Drug Store
10.10.4 Retail Pharmacies
10.10.5 Online Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Urinary Tract Infection Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Urinary Tract Infection Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Urinary Tract Infection Treatment Market Size Forecast by Type
11.6.1 Complicated UTI
11.6.2 Recurring Complicated UTI
11.6.3 Uncomplicated UTI
11.6.4 Neurogenic Bladder Infections
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Urinary Tract Infection Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Gynaecology and Urology Clinics
11.10.3 Drug Store
11.10.4 Retail Pharmacies
11.10.5 Online Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Urinary Tract Infection Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Urinary Tract Infection Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Urinary Tract Infection Treatment Market Size Forecast by Type
12.6.1 Complicated UTI
12.6.2 Recurring Complicated UTI
12.6.3 Uncomplicated UTI
12.6.4 Neurogenic Bladder Infections
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Urinary Tract Infection Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Gynaecology and Urology Clinics
12.10.3 Drug Store
12.10.4 Retail Pharmacies
12.10.5 Online Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Urinary Tract Infection Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Urinary Tract Infection Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Urinary Tract Infection Treatment Market Size Forecast by Type
13.6.1 Complicated UTI
13.6.2 Recurring Complicated UTI
13.6.3 Uncomplicated UTI
13.6.4 Neurogenic Bladder Infections
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Urinary Tract Infection Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Gynaecology and Urology Clinics
13.10.3 Drug Store
13.10.4 Retail Pharmacies
13.10.5 Online Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Urinary Tract Infection Treatment Market: Competitive Dashboard
14.2 Global Urinary Tract Infection Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Novartis
14.3.3 Pfizer
14.3.4 Merck
